Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0002064832-26-000062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-20 | 2026-02-18 | ORGO | Freedman Lori | Chief Admin, Legal Off | A - Grant | $0.00 | +245.9K | 994.8K | +33% | $0 |
| D | 2026-02-20 | 2026-02-18 | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $3.84 | -14.3K | 1.02M | -1% | -$54.8K |
| D | 2026-02-20 | 2026-02-18 | ORGO | Freedman Lori | Chief Admin, Legal Off | A - Grant | $0.00 | +115.8K | 115.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-18 | A | A | 42,780 | $0.00 | 1,037,622 | D | — | — | (F2) Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones. |
| 2 | Common | Class A Common Stock | 2026-02-18 | F | D | 14,267 | $3.84 | 1,023,355 | D | — | — | |
| 3 | Common | Class A Common Stock | 2026-02-18 | A | A | 203,125 | $0.00 | 994,842 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-02-18 | A | A | 115,812 | $0.00 | 115,812 | D | $3.84 · — to 2036-02-18 | 115,812 Class A Common Stock | (F3) The option becomes exercisable in equal annual installments over four years beginning February 15, 2026. |